HuMurine Technologies, Inc. is a technology leader in standardization and commercialization of humanized immune system mice for the advancement in testing of oncology drugs, gene therapies and agents to promote hematopoiesis. HuMurine offers contract research services in cancer biology (immunotherapy), infectious diseases (vaccines or antiviral therapies), inflammation (cytokine release syndrome, immunity assessment), assessment of immune response against human restricted diseases (human antibody or T cell response), and gene therapies. The companys flagship platform is the Humanized Immune System NOG (Hu-M) mouse and also includes the humanized GM-CSF/hIL3 NOG mouse (Hu-3GM mouse) which have wide ranging applications in the field of basic and applied human disease research.
